Clinical Trial Details


Research Study Summary

COAST: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients with Radiographic Axial Spondyloarthritis


Local doctors are looking for people with Ankylosing Spondylitis (AS) for a clinical research study of an investigational drug. AS is a type of inflammatory arthritis that mostly affects the spine.

To Learn more

CW ID: 225692
Date Last Changed: July 21, 2017

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Lead Sponsor
Eli Lilly
52 Weeks
Facility Type


Inclusion Criteria:
  • Are at least 18 years old
  • Have ankylosing spondylitis

The study physician will check other requirements to confirm that you qualify for this study. Health insurance is not required.

More Info

If you qualify for this study, you may receive the following:
  • Study-related care from a local doctor at no cost to you or your health insurance.
  • Investigational medication
  • Possible compensation for time and travel


Richard Robinson, BSN, RN, CCRC, Study Coordinator
The Osteoporosis & Clinical Trials Center
Klein & Associates, M.D., P.A
346 Mill Street
Hagerstown, MD 21502
Phone: 301-724-4337 x1216
Fax: 301-724-3276

View Map

Research Center Information:

The Osteoporosis & Clinical Trials Center

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.